Обинутузумаб - analogs
Components: Obinutuzumab |
|||||||||
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: — Instructions Обинутузумаб | |||||||||
|
ⓘXEnter drugs for checking interactions through a quick button search . Extractum rhozomata cum radicibus Valerianae, herbae Melissae, herbae Hiperici perforate, foliorum et flores Crataegti, herbae Passiflorae, fructus Humuli lupuli, flores Sambucci nigrae+Quaifenesinum ✘ (incl) Прамитропил ✘ (incl) Cefazolin sodium sterile ✘ (incl) Эхинацея-Парафарм ✘ (incl) Orensia ✘ (incl) Flexen ✘ (incl) Fortazim ✘ (incl) Артикаин-ЭГЕН с адреналином ✘ (incl) Mercaptopurin-nativ ✘ (incl) Лактакид ✘ (incl) Соляриум ✘ (incl) Semax solution ✘ (incl) Фиточай «Фитопростат» ✘ (incl) Allergena ex pollene toraxaci, platensium et cultorum oramimem pro diagnostica et curatione (Poa pratensis) ✘ (incl) Gerimax ✘ |
|
ⓘX diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘXAnalogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | neutral Gazyva | 1750€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘXAnalogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 51% 495-545€ Arzerra Negative 🔍 [Ofatumumab]
- 49% 2075€ Blincyto neutral [Blinatumomab]
- 49% 8873.4€ Besponsa neutral [Inotuzumab ozogamicin]
- 49% — Campath Negative 🔍 [Alemtuzumab]
- 46% — Бонспри Negative 🔍 [Ofatumumab]
- 40% — Nilotinib-nativ neutral [Nilotinib]
- 40% 950-1049.7€ Tasigna neutral [Nilotinib]
- 40% 324.5€ Иглиб neutral [Imatinib]
- 40% — Gistamel neutral [Imatinib]
- 40% — Nilotinib hydrochloride monohydrate neutral [Nilotinib]
- 40% — Iimatinib mesilate neutral [Imatinib]
- 40% — Imatinib-Actavis neutral [Imatinib]
- 40% — Nilotinib neutral [Nilotinib]
- 40% — Imatinib medac neutral [Imatinib]
- 40% — Citonib neutral [Imatinib]
- 40% — Imatinib-Alvogen neutral [Imatinib]
- 40% 3947.9€ Калквенс neutral [Akalabrutinib]
- 40% — Imagliv neutral [Imatinib]
- 40% — Иматиниба мезилат форма Альфа neutral [Imatinib]
- 40% — Иматиниба мезилат α-форма neutral [Imatinib]
- 40% — Калквенс Т neutral [Akalabrutinib]
- 40% — Нилотиниба гидрохлорид дигидрат (Форма А) neutral [Nilotinib]
- 40% — Нилотиниб-Бинергия neutral [Nilotinib]
- 40% — Иматиниба мезилат neutral [Imatinib]
- 40% — Нилотиниб-Фарм-Синтез neutral [Nilotinib]
- 40% — Нилотиниб-промомед neutral [Nilotinib]
- 40% — Нилотиниб Фармасинтез neutral [Nilotinib]
- 40% — Нилотиниб Канон neutral [Nilotinib]
- 40% — Лотнилиб neutral [Nilotinib]
- 40% — Нилотиниб-химрар neutral [Nilotinib]
- 40% — Акалабрутиниб-Промомед neutral [Akalabrutinib]
- 37% 3068€ Lemtrada Negative 🔍 [Alemtuzumab]
- 37% 755-758€ Bosulif neutral [Bosutinib]
- 36% 45-106€ Рибомустин neutral [Bendamustine]
- 36% — Lanvis neutral [Tioguanine]
- 34% 748.1€ Empliciti neutral [Elotuzumab]
- 34% — Меркаптопурина моногидрат neutral [Mercaptopurine]
- 34% — Сцембликс neutral [Asciminib]
- 34% 570€ Bavencio neutral [Avelumab]
- 34% — Remobav neutral [Catumaxomab]
- 34% — Бозутиниб Фармасинтез neutral [Bosutinib]
- 34% — Бозутиниб-химрар neutral [Bosutinib]
- 34% — Бозутиниб neutral [Bosutinib]
- 34% — Даратумиа neutral [Daratumumab]
- 34% — Имджудо neutral [Tremelimumab]
- 34% — Бозутиниб-промомед neutral [Bosutinib]
- 34% — Бозутиниб-ДЖИЭФСИ neutral [Bosutinib]
- 33% 1440€ Venclexta neutral [Venetoclax]
- 33% — Флутотера neutral [Fludarabine]
- 33% — Fludarabine phosphate neutral [Fludarabine]
Learn more about the selection of analogues
▶
- The drug has «Обинутузумаб» 1 full analog, the cheapest - Gazyva (1750€); 51 analog by action, the most similar - Arzerra (495-545€).
- Medical online service has selected the best substitutes for Обинутузумаб based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Обинутузумаб to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.